Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (81-90 of 288) with videos related to

Pageof 29
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysisSaad A Khan, Sandi L Pruitt, Lei Xuan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2010
Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse populationDrew W Rasco, Jingsheng Yan, Yang Xie, et al.
Journal of Oncology Practice|October 12, 2017
Institutional Scientific Review of Cancer Clinical Research Protocols: A Unique Requirement That Affects Activation TimelinesNing Ning, Jingsheng Yan, Martin F Dietrich, et al.
Clinical Lung Cancer|June 4, 2017
Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical TrialsSandra Garcia, Jessica M Saltarski, Jingsheng Yan, et al.
Frontiers in Oncology|November 3, 2025
Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims dataBenjamin J Drapkin, David J Morrell, Regina Grebla, et al.
Oncotarget|June 1, 2018
Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the National Cancer DatabaseMatthew MacLean, Xin Luo, Shidan Wang, et al.
Oncology Nursing Forum|February 22, 2017
Oncology Nursing Perceptions of Patient Electronic Portal Use: A Qualitative AnalysisDavid E Gerber, Muhammad Shaalan Beg, Tobi Duncan, et al.
Lung|August 2, 2019
Increasing Numbers and Reported Adverse Events in Patients with Lung Cancer Undergoing Inpatient Lung Biopsies: A Population-Based AnalysisMitchell S von Itzstein, Arjun Gupta, Kristin C Mara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Optic neuropathy and blindness associated with crizotinib for non-small-cell lung cancer with EML4-ALK translocationStephen G Chun, Puneeth Iyengar, David E Gerber, et al.
The Oncologist|April 2, 2020
Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung CancerVinita Popat, Rong Lu, Murtaza Ahmed, et al.
Pageof 29

Showing results (81-90 of 288) with videos related to

Sort By:
Pageof 29
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysisSaad A Khan, Sandi L Pruitt, Lei Xuan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2010
Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse populationDrew W Rasco, Jingsheng Yan, Yang Xie, et al.
Journal of Oncology Practice|October 12, 2017
Institutional Scientific Review of Cancer Clinical Research Protocols: A Unique Requirement That Affects Activation TimelinesNing Ning, Jingsheng Yan, Martin F Dietrich, et al.
Clinical Lung Cancer|June 4, 2017
Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical TrialsSandra Garcia, Jessica M Saltarski, Jingsheng Yan, et al.
Frontiers in Oncology|November 3, 2025
Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims dataBenjamin J Drapkin, David J Morrell, Regina Grebla, et al.
Oncotarget|June 1, 2018
Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the National Cancer DatabaseMatthew MacLean, Xin Luo, Shidan Wang, et al.
Oncology Nursing Forum|February 22, 2017
Oncology Nursing Perceptions of Patient Electronic Portal Use: A Qualitative AnalysisDavid E Gerber, Muhammad Shaalan Beg, Tobi Duncan, et al.
Lung|August 2, 2019
Increasing Numbers and Reported Adverse Events in Patients with Lung Cancer Undergoing Inpatient Lung Biopsies: A Population-Based AnalysisMitchell S von Itzstein, Arjun Gupta, Kristin C Mara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Optic neuropathy and blindness associated with crizotinib for non-small-cell lung cancer with EML4-ALK translocationStephen G Chun, Puneeth Iyengar, David E Gerber, et al.
The Oncologist|April 2, 2020
Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung CancerVinita Popat, Rong Lu, Murtaza Ahmed, et al.
Pageof 29